Track topics on Twitter Track topics that are important to you
Biozentrum HalleWeinbergweg 22
Phone: 49 345 68500-0
Fax: 49 345 68500-58`
(Alliance for Cancer Gene Therapy) ACGT provides $1.5 million in cancer gene therapy grants to tackle solid tumors.
Alliance for Cancer Gene Therapy (ACGT), the nation's only public charity exclusively funding cancer cell and
Stomatal movement plays an essential role in plant responses to drought stress, and the actin cytoskeleton and abscisic acid (ABA) are two important components of this process. Little is known about t...
Die ACGT ProGenomics AG ist das weltweit erste Unternehmen, dem es gelungen ist, einen blut-basierten Früherkennungstest für die Alzheimer-Erkrankung zu entwickeln. Mit AlzAlert, einem sensitiven, r...
Established in 2001, ACGT is the nationâs only nonprofit dedicated exclusively to funding cell and gene therapy research for all types of cancer. One hundred percent of contr...
ACGT, Inc. was established in 1993 with the goal of providing high quality reliable DNA sequencing services to the research community in Chicagoland area. As the demand for DNA se...
ACGT, Inc. is a contract research support company that provides a broad range of DNA sequencing and molecular biology services to the pharmaceutical, biotechnology, academic, and government sectors. O...
We have published hundreds of ACGT ProGenomics AG news stories on BioPortfolio along with dozens of ACGT ProGenomics AG Clinical Trials and PubMed Articles about ACGT ProGenomics AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of ACGT ProGenomics AG Companies in our database. You can also find out about relevant ACGT ProGenomics AG Drugs and Medications on this site too.
Psychiatry is the study of mental disorders and their diagnosis, management and prevention. Conditions include schizophrenia, severe depression and panic disorders among others. There are pharmaceutical treatments as well as other therapies to help...
Parkinson's is a progressive neurological condition, affecting one person in every 500, 95% of which are over 40. It is caused by degeneration of more than 70% of the substantia nigra, which depletes the dopamine (the neurotransmitter involved in pro...